News
Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...
Now 33, Stephenson was one of the first to receive sickle cell gene therapy in a clinical trial six years ago. Before the treatment, Stephenson lived her life on a razor's edge.
Some doctors told him he'd live with the disease forever, but Khaled Alsheebani never stopped believing treatments would advance one day.
By Dec. 20, the FDA will determine the fate of a second gene therapy for people with sickle cell, lovo-cel by Bluebird Bio, which relies on a more established approach to gene therapy.
Hosted on MSN9mon
What Is Gene Therapy for Sickle Cell Disease? - MSNHow Sickle Cell Gene Therapy Works. The idea behind sickle cell gene therapy is that a person would receive some sort of gene that would allow their red blood cells to function normally.
The FDA on Friday also approved a second treatment for sickle cell disease, called Lyfgenia, a gene therapy from drugmaker Bluebird Bio. Both treatments work by genetically modifying a patient’s ...
Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new ...
Gene therapy caused some disasters early on, but it's finally started to work, and several experimental gene therapies are showing promise for sickle cell disease now. MARTIN: Well, how so?
The treatment, however, also sparks mixed feelings among both Black sickle cell patients and doctors, who are concerned about potential side effects, costs and access to the therapy, will cost $2. ...
Expert joins CBS New York to discuss new sickle cell treatment 02:46. Britain's medicines regulator has authorized the world's first gene therapy treatment for sickle cell disease, in a move that ...
6h
WWLP on MSNSickle cell advocates on Beacon HillAround 2,500 people are living with sickle cell disease in the Bay State, and they are advocating for a bill that would improve quality of life for all those dealing with the disease.
Now, 33, Stephenson was one of the first to receive sickle cell gene therapy in a clinical trial six years ago. Before the treatment, Stephenson lived her life on a razor's edge.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results